サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/26 | 1,430 | 1,470 | 1,420 | 1,461 | +27 | +1.9% | 193,000 |
2020/08/25 | 1,452 | 1,465 | 1,434 | 1,434 | -17 | -1.2% | 293,900 |
2020/08/24 | 1,501 | 1,510 | 1,446 | 1,451 | -61 | -4% | 332,100 |
2020/08/21 | 1,516 | 1,528 | 1,500 | 1,512 | -12 | -0.8% | 188,900 |
2020/08/20 | 1,542 | 1,543 | 1,510 | 1,524 | -18 | -1.2% | 229,300 |
2020/08/19 | 1,515 | 1,542 | 1,502 | 1,542 | +37 | +2.5% | 284,400 |
2020/08/18 | 1,520 | 1,532 | 1,477 | 1,505 | +3 | +0.2% | 429,900 |
2020/08/17 | 1,510 | 1,513 | 1,469 | 1,502 | +7 | +0.5% | 256,900 |
2020/08/14 | 1,439 | 1,499 | 1,436 | 1,495 | +69 | +4.8% | 363,300 |
2020/08/13 | 1,424 | 1,451 | 1,416 | 1,426 | +4 | +0.3% | 213,800 |
2020/08/12 | 1,405 | 1,434 | 1,396 | 1,422 | +6 | +0.4% | 142,000 |
2020/08/11 | 1,390 | 1,433 | 1,390 | 1,416 | +26 | +1.9% | 160,700 |
2020/08/07 | 1,396 | 1,411 | 1,378 | 1,390 | -14 | -1% | 189,000 |
2020/08/06 | 1,420 | 1,425 | 1,377 | 1,404 | -25 | -1.7% | 225,800 |
2020/08/05 | 1,415 | 1,432 | 1,390 | 1,429 | +10 | +0.7% | 153,600 |
2020/08/04 | 1,367 | 1,447 | 1,366 | 1,419 | +39 | +2.8% | 232,900 |
2020/08/03 | 1,319 | 1,392 | 1,299 | 1,380 | +42 | +3.1% | 298,300 |
2020/07/31 | 1,354 | 1,397 | 1,338 | 1,338 | -60 | -4.3% | 242,500 |
2020/07/30 | 1,363 | 1,399 | 1,356 | 1,398 | +39 | +2.9% | 228,000 |
2020/07/29 | 1,410 | 1,416 | 1,357 | 1,359 | -69 | -4.8% | 314,900 |
2020/07/28 | 1,457 | 1,481 | 1,428 | 1,428 | -57 | -3.8% | 320,900 |
2020/07/27 | 1,553 | 1,554 | 1,478 | 1,485 | -28 | -1.9% | 227,300 |
2020/07/22 | 1,530 | 1,540 | 1,504 | 1,513 | -33 | -2.1% | 156,400 |
2020/07/21 | 1,522 | 1,550 | 1,519 | 1,546 | +40 | +2.7% | 261,700 |
2020/07/20 | 1,500 | 1,532 | 1,480 | 1,506 | +11 | +0.7% | 203,400 |
2020/07/17 | 1,549 | 1,551 | 1,495 | 1,495 | -56 | -3.6% | 395,800 |
2020/07/16 | 1,555 | 1,606 | 1,549 | 1,551 | -4 | -0.3% | 330,900 |
2020/07/15 | 1,545 | 1,560 | 1,523 | 1,555 | +20 | +1.3% | 275,500 |
2020/07/14 | 1,539 | 1,544 | 1,511 | 1,535 | +6 | +0.4% | 235,100 |
2020/07/13 | 1,552 | 1,560 | 1,505 | 1,529 | -52 | -3.3% | 651,500 |
2020/07/10 | 1,602 | 1,612 | 1,575 | 1,581 | -38 | -2.3% | 292,800 |
2020/07/09 | 1,692 | 1,700 | 1,618 | 1,619 | -84 | -4.9% | 386,000 |
2020/07/08 | 1,679 | 1,712 | 1,646 | 1,703 | +24 | +1.4% | 204,100 |
2020/07/07 | 1,680 | 1,682 | 1,628 | 1,679 | +10 | +0.6% | 255,300 |
2020/07/06 | 1,589 | 1,680 | 1,589 | 1,669 | +47 | +2.9% | 343,700 |
2020/07/03 | 1,574 | 1,626 | 1,566 | 1,622 | +25 | +1.6% | 389,900 |
2020/07/02 | 1,680 | 1,693 | 1,595 | 1,597 | -83 | -4.9% | 578,200 |
2020/07/01 | 1,652 | 1,713 | 1,648 | 1,680 | +8 | +0.5% | 364,100 |
2020/06/30 | 1,717 | 1,724 | 1,628 | 1,672 | -5 | -0.3% | 429,800 |
2020/06/29 | 1,751 | 1,752 | 1,677 | 1,677 | -98 | -5.5% | 829,700 |
2020/06/26 | 1,820 | 1,840 | 1,775 | 1,775 | -66 | -3.6% | 825,900 |
2020/06/25 | 1,900 | 1,980 | 1,789 | 1,841 | +78 | +4.4% | 3,776,200 |
2020/06/24 | 1,787 | 1,819 | 1,746 | 1,763 | -24 | -1.3% | 524,200 |
2020/06/23 | 1,820 | 1,839 | 1,769 | 1,787 | -27 | -1.5% | 597,200 |
2020/06/22 | 1,781 | 1,830 | 1,750 | 1,814 | +29 | +1.6% | 701,900 |
2020/06/19 | 1,769 | 1,785 | 1,744 | 1,785 | +21 | +1.2% | 416,300 |
2020/06/18 | 1,805 | 1,810 | 1,720 | 1,764 | -53 | -2.9% | 673,500 |
2020/06/17 | 1,811 | 1,860 | 1,768 | 1,817 | +46 | +2.6% | 1,166,600 |
2020/06/16 | 1,589 | 1,831 | 1,580 | 1,771 | +238 | +15.5% | 1,981,800 |
2020/06/15 | 1,657 | 1,684 | 1,528 | 1,533 | -100 | -6.1% | 1,050,200 |
1151~
1200
件表示中 / 2464件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 266,900円 | - | - | 0.00% | - | 123.62倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 379,600円 | +30.5% | +111.0% | 5.01% | 10.70倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 264,300円 | +13.9% | +6.6% | 2.65% | 6.89倍 | 0.82倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 247,600円 | +21.7% | +999.9% | 0.00% | 10.31倍 | 3.41倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム